A carregar...

Can novel therapeutics halt the amyloid cascade?

The amyloid hypothesis provides a basis for the development of new therapeutic strategies in Alzheimer's disease. Two large trials have recently been published. The first is a phase 2 study of passive immunotherapy with bapineuzumab, a humanized anti-Aβ monoclonal antibody directed against the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Prins, Niels D, Visser, Pieter Jelle, Scheltens, Philip
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2876783/
https://ncbi.nlm.nih.gov/pubmed/20388189
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/alzrt28
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!